Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Naiya Hitesh Shah

AMC Dental College and Hospital, India

Title: Oral submucous fibrosis-A dreadful malady for the ages

Biography

Biography: Naiya Hitesh Shah

Abstract

Oral submucous fibrosis (OSMF) has been well established in Indian Medical Literature since the time of Sushruta. In

modern literature, this condition was first described by Schwartz in 1952. It is a chronic, insidious, progressive, irreversible,

crippling fibrotic disorder which not only involves the submucosa of the oral cavity and oropharynx but sometimes also

the esophagus and rarely the larynx. OSMF is well recognized “precancerous condition” which is characterized by changes

in the connective tissue fibers of the lamina propria and its deeper parts leading to stiffness of the mucosa and ultimately

restricted mouth opening. All forms of tobacco, excessive chili consumption, nutritional deficiencies, areca nut/betel nut usage,

immunologic derangements and much more have been suggested in its pathogenesis, but areca nut is implicated as the prime

etiologic agent. Areca nut chewing is a habit practiced predominately in Southeast Asia and India since time immemorial, but

alarmingly this condition is now being reported from Western countries as well. Reduced mouth opening, inability to whistle

or blow out, recurrent oral ulcers, burning sensation in the mouth, difficulty in swallowing, nasal voice, hesitation while

socializing with others etc., adversely influence the quality of life of such patients. OSMF’s malignant potential, psychological

distress, restriction of social activities, diminished physical health, economic problems related to treatment are bourgeoning

matters of concern which demand our pressing attention. These appeals for treatment of OSMF which aims at the release of

fibrosis to provide a long-term stable mouth opening primarily. Various treatment modalities are practiced at our institution

for the management of OSMF, which will be discussed in this oral presentation.